China Shineway Pharmaceutical Group Limited (2877.HK)

9.350 +0.090 (+0.97%) At close: 04:08PM HKT

China Shineway Pharmaceutical Group Limited

No. 168, Shiluan Street
Luan Cheng District
Shijiazhuang 051430
China
86 31 1880 30066
https://www.shineway.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zhenjiang Li	Co-Founder & Executive Chairman	4.82M	N/A	1955
Ms. Yunxia Xin	Co-Founder & Executive Director	3.36M	N/A	1963
Mr. Huimin Li	Executive Director	2.25M	N/A	1968
Mr. Bun Ching Lee	Financial Controller & Company Secretary	N/A	N/A	1973
Mr. King Kuen Hung	Director of Investor Relation	35.65k	N/A	1966
Mr. Yudong Zhang	General Manager of Sales & Marketing	N/A	N/A	1974

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd.

Corporate governance

China Shineway Pharmaceutical Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.